Back
The Allstate Corp. Vs. Alnylam Pharmaceuticals, Inc. Industry Stock Comparison
Buy
58
ALL
The Allstate Corp.
Last Price:
$208.18
Seasonality Move:
1.7%
Sell
43
ALNY
Alnylam Pharmaceuticals, Inc.
Last Price:
$397.66
Seasonality Move:
0.84%
Buy
58
The Allstate Corp. (ALL)
is a Buy
Is The Allstate Corp. a Buy, Sell or Hold?
-
The current The Allstate Corp. [ALL] share price is $209.10. The Score for ALL is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
ALL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Alnylam Pharmaceuticals, Inc. (ALNY)
is a Sell
Is Alnylam Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $397.25. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALL Stock Price Chart
What is The Allstate Corp.'s stock price today?
-
The The Allstate Corp. share price today is $209.10The current trend is moderately bullish and ALL is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals, Inc.'s stock price today?
-
The Alnylam Pharmaceuticals, Inc. share price today is $397.25Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.7 | Buy |
| Relative Strength Index (14 RSI): | 54.16 | Buy |
| Chaikin Money Flow: | 147839 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (204.28 - 211.56) | Buy |
| Bollinger Bands (100): | (198.56 - 211.3) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -12.66 | Sell |
| Relative Strength Index (14 RSI): | 37.48 | Sell |
| Chaikin Money Flow: | 260878 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (393.55 - 447.35) | Sell |
| Bollinger Bands (100): | (423.62 - 470.16) | Sell |
ALL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 207.8 | Buy |
| 20-day SMA: | 206.81 | Buy |
| 50-day SMA: | 204.16 | Buy |
| 200-day SMA: | 202.31 | Buy |
| 8-day EMA: | 208.29 | Buy |
| 20-day EMA: | 207.64 | Buy |
| 50-day EMA: | 206.17 | Buy |
| 200-day EMA: | 200.97 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 400.01 | Sell |
| 20-day SMA: | 414.82 | Sell |
| 50-day SMA: | 438.02 | Sell |
| 200-day SMA: | 370.41 | Buy |
| 8-day EMA: | 400.42 | Sell |
| 20-day EMA: | 411.3 | Sell |
| 50-day EMA: | 427.39 | Sell |
| 200-day EMA: | 383.76 | Buy |
The Allstate Corp. Earnings Growth & ALL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.93 per share, and an increase next year of $0.19 per share.
Alnylam Pharmaceuticals, Inc. Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.23 per share, and an increase next year of $6.60 per share.
The Allstate Corp. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||